Enoxaparin Sodium NDC 63323-584

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-584Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0584Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-584-65	63323058465	10 BLISTER PACK in 1 CARTON (63323-584-65) / 1 SYRINGE in 1 BLISTER PACK (63323-584-63) / .8 mL in 1 SYRINGEMarketed from Apr 23, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enoxaparin Sodium
Generic name (nonproprietary): enoxaparin sodium
Active ingredients: Enoxaparin sodium — 80 mg/.8mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078990
Marketing start: Apr 23, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Low-Molecular-Weight (Chemical structure)
Identifiers: Product ID 63323-584_2b6f0c59-240a-48ec-9cef-e55cc4b52274SPL ID 2b6f0c59-240a-48ec-9cef-e55cc4b52274SPL set ID c3be543e-8aff-4311-bf77-e7a5a814ca6fRxCUI 854228, 854235, 854238, 854241, 854248UNII 8NZ41MIK1O
Pharmacologic class: Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323058465 followed by a unit qualifier and the quantity

Package 63323-0584-65. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 9, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Enoxaparin sodium injection is a low molecular weight heparin [LMWH] indicated for: • Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) • Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2 ) • Outpatient treatment of acute DVT without pulmonary embolism ( 1.2 ) • Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction [MI] ( 1.3 ) • Treatment of acute ST-segment elevation myocardial infarction [STEMI] managed medically or with subsequent percutaneous coronary intervention [PCI] ( 1.4 ) …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078990

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078990
Product	Strength	Form · route	Labeler	Product NDC
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Sagent Pharmaceuticals	25021-410
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-655
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sagent Pharmaceuticals	25021-411
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Cardinal Health 107, LLC	55154-9586
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Civica, Inc.	72572-280
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Gland Pharma Limited	68083-634
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Gland Pharma Limited	68083-635
Enoxaparin Sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Gland Pharma Limited	68083-639
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Gland Pharma Limited	68083-636
Enoxaparin Sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Gland Pharma Limited	68083-637
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Gland Pharma Limited	68083-638
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Gland Pharma Limited	68083-640
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-559
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-559
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-564
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-564
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-566
Enoxaparin Sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-566
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-586
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-586

Showing 20 of 21.